New cancer Drug's hidden impact on cough medicine revealed
NCT ID NCT07241065
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how a cancer drug called capivasertib changes the way the body processes dextromethorphan, a common cough suppressant. Researchers will give 42 healthy adults dextromethorphan alone and then with capivasertib to measure drug levels in the blood. The goal is to understand potential drug interactions for safer use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
capivasertib and dextromethorphan
What this could lead to
If successful, this study could help doctors understand how capivasertib interacts with other drugs, leading to safer dosing guidelines.
What could go wrong
This is an early-stage, small study in healthy people, not patients. Results may not predict effects in sick individuals or lead directly to new treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGBerlin, 14050, Germany